Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting

WILMINGTON, Del. –(BUSINESS WIRE)–May 26, 2022– Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress ( June 9-17 ; virtual and in Vienna ).